§ 90-113.70 – Short title.
90-113.70. Short title. This Article shall be known and may be cited as the "North Carolina Controlled Substances Reporting System Act." (2005-276, s. 10.36(a).)
§ 90-113.71 – Legislative findings and purpose.
90-113.71. Legislative findings and purpose. (a) The General Assembly makes the following findings: (1) North Carolina is experiencing an epidemic of poisoning deaths from unintentional drug overdoses. (2) Since 1997, the number of deaths from unintentional drug overdoses has increased threefold, from 228 deaths in 1997 to 690 deaths in 2003. (3) The number of […]
§ 90-113.72 – Definitions.
90-113.72. Definitions. The following definitions apply in this Article: (1) Commission. – The Commission for Mental Health, Developmental Disabilities, and Substance Abuse Services established under Part 4 of Article 3 of Chapter 143B of the General Statutes. (2) Controlled substance. – A controlled substance as defined in G.S. 90-87(5). (3) Department. – The Department of […]
§ 90-113.73 – Requirements for controlled substances reporting system; civil penalties for failure to properly report.
90-113.73. Requirements for controlled substances reporting system; civil penalties for failure to properly report. (a) The Department shall establish and maintain a reporting system of prescriptions for all Schedule II through V controlled substances. Each dispenser shall submit the information in accordance with transmission methods and frequency established by rule by the Commission. The Department […]
§ 90-113.73A – Expand monitoring capacity; report.
90-113.73A. Expand monitoring capacity; report. (a) The North Carolina Controlled Substances Reporting System shall expand its monitoring capacity by establishing data use agreements with the Prescription Behavior Surveillance System. In order to participate, the CSRS shall establish a data use agreement with the Center of Excellence at Brandeis University no later than January 1, 2016. […]
§ 90-113.74 – Confidentiality.
90-113.74. Confidentiality. (a) Prescription information submitted to the Department is privileged and confidential, is not a public record pursuant to G.S. 132-1, is not subject to subpoena or discovery or any other use in civil proceedings, and except as otherwise provided below may only be used (i) for investigative or evidentiary purposes related to violations […]
§ 90-113.74A – Mandatory prescriber registration for access to controlled substances reporting system.
90-113.74A. Mandatory prescriber registration for access to controlled substances reporting system. Within 30 days after obtaining an initial or renewal license that confers the authority to prescribe a controlled substance for the purpose of providing medical care for a patient, the licensee shall demonstrate to the satisfaction of the licensing board that he or she […]
§ 90-113.74B – Mandatory dispenser registration for access to controlled substances reporting system; exception.
90-113.74B. Mandatory dispenser registration for access to controlled substances reporting system; exception. (a) Within 30 days after obtaining an initial or renewal license to practice pharmacy, the licensee shall demonstrate to the satisfaction of the North Carolina Board of Pharmacy that he or she is registered for access to the controlled substances reporting system. A […]
§ 90-113.74C – Practitioner use of controlled substances reporting system; mandatory reporting of violations.
90-113.74C. Practitioner use of controlled substances reporting system; mandatory reporting of violations. (a) Prior to initially prescribing a targeted controlled substance to a patient, a practitioner shall review the information in the controlled substances reporting system pertaining to the patient for the 12-month period preceding the initial prescription. For every subsequent three-month period that the […]
§ 90-113.74D – Dispenser use of controlled substances reporting system.
90-113.74D. Dispenser use of controlled substances reporting system. (a) Prior to dispensing a targeted controlled substance, a dispenser shall review the information in the controlled substances reporting system pertaining to the patient for the preceding 12-month period and document this review under any of the following circumstances: (1) The dispenser has a reasonable belief that […]
§ 90-113.74E – Certification of diversion investigators and diversion supervisors.
90-113.74E. Certification of diversion investigators and diversion supervisors. Pursuant to its authority under G.S. 17C-6 and G.S. 17E-4, the North Carolina Criminal Justice Education and Training Standards Commission and the North Carolina Sheriffs’ Education and Training Standards Commission, in consultation with the Department of Justice, North Carolina Justice Academy, and State Bureau of Investigation, shall […]
§ 90-113.75 – Civil penalties; other remedies; immunity from liability.
90-113.75. Civil penalties; other remedies; immunity from liability. (a) A person who intentionally, knowingly, or negligently releases, obtains, or attempts to obtain information from the system in violation of a provision of this Article or a rule adopted pursuant to this Article shall be assessed a civil penalty by the Department not to exceed ten […]
§ 90-113.75A – Creation of Controlled Substances Reporting System Fund.
90-113.75A. Creation of Controlled Substances Reporting System Fund. (a) The Controlled Substances Reporting System Fund is created within the Department as a special revenue fund. The Department shall administer the Fund. The Department shall use the Fund only for operation of the controlled substances reporting system and to carry out the provisions of this Article. […]
§ 90-113.75B – Annual report to General Assembly and licensing boards.
90-113.75B. Annual report to General Assembly and licensing boards. Annually on February 1, beginning February 1, 2019, the Department shall report to the Joint Legislative Oversight Committee on Health and Human Services, the North Carolina Medical Board, the North Carolina Board of Podiatry Examiners, the North Carolina Board of Nursing, the North Carolina Dental Board, […]
§ 90-113.75E – Opioid and Prescription Drug Abuse Advisory Committee; statewide strategic plan[Effective until January 1, 2023]
90-113.75E. Opioid and Prescription Drug Abuse Advisory Committee; statewide strategic plan. [Effective until January 1, 2023] (a) There is hereby created the Opioid and Prescription Drug Abuse Advisory Committee, to be housed in and staffed by the Department. The Committee shall develop and, through its members, implement a statewide strategic plan to combat the problem […]
§ 90-113.76 – Commission for Mental Health, Developmental Disabilities, and Substance Abuse Services to adopt rules.
90-113.76. Commission for Mental Health, Developmental Disabilities, and Substance Abuse Services to adopt rules. The Commission for Mental Health, Developmental Disabilities, and Substance Abuse Services shall adopt rules necessary to implement this Article. (2005-276, s. 10.36(a).)